Improving Cancer Pain Management Amid the Opioid Crisis
Research into opioid alternatives for cancer-related pain has stalled, however substance use disorders remain problematic.
Pain Management
Cabazitaxel Linked to Better Pain Reduction in mCRPC
A new analysis of men in the CARD study showed that cabazitaxel improved pain response and decreased the likelihood of pain progression compared with either abiraterone or enzalutamide.
Emerging Clinical Tool Predicts Risk of Persistent Use of Opioids After Treatment in Patients With Cancer
Investigators at UCSD sought to create a tool to help clinicians predict patients’ risk of persistent opioid use after treatment.
Consider CBD-Drug Interaction Potential: An Expert Interview
To shed light on this complex subject, MPR interviewed Joshua D Brown, PharmD, PhD, Assistant Professor, Pharmaceutical Outcomes & Policy.
Factors Predict Adverse Opioid-Related Outcomes in Cancer Survivors
Demographic, cancer, and treatment factors can predict outcomes with high level of discrimination.
Patterns of Gabapentinoid Use Over Time in Patients With Cancer
A cross-sectional survey examined Medical Expenditure Panel Survey data on prescriptions for gabapentinoid medications given for pain management in patients with cancer.
Postop Opioid Rx 7-fold Higher in US, Canada Versus Sweden
About 75% of patients in US and Canada fill opioid prescriptions versus 11% in Sweden.
Opioids Likely Unnecessary for Post-Vasectomy Pain
In a study, withholding opioids after vasectomy did not increase subsequent medical encounters for scrotal pain.
eGFR Affects Risk for Opioid-Related Death, Hospitalization
Relative risk for death associated with opioids higher at lower estimated glomerular filtration rate
New Opioid Rx Rules Coming for US Employees’ Health Plans
New Federal Employee Health Benefits Program rules are meant to prevent overprescribing
Next post in Urology
